Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma (MasterPlan)

This study is currently recruiting participants.
Verified July 2013 by St. Louis University
Sponsor:
Information provided by (Responsible Party):
St. Louis University
ClinicalTrials.gov Identifier:
NCT01130194
First received: May 24, 2010
Last updated: July 17, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2026
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)
Publications:
Fesler MJ, Osman M, Glauber J, Petruska PJ. C-MOPP: Results of a Forgotten Regimen in the Era of Rituximab and PET. Blood (ASH Annual Meeting Abstracts 2009) #4577.